New study seeks best treatment for elderly myeloma patients
NCT ID NCT03829371
First seen Jan 07, 2026 · Last updated May 24, 2026 · Updated 25 times
Summary
This study looks at which treatment works best for older adults (65+) with multiple myeloma who cannot have a stem cell transplant. It compares standard drug combinations, with or without daratumumab, to see which improves survival and quality of life. The goal is to find the best approach for this group, considering their overall health and daily functioning.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Dipartimento di Biotecnologie Molecolari e Scienze per la Salute
Torino, TO, 10126, Italy
Conditions
Explore the condition pages connected to this study.